Divis Laboratories Ltd logo

Divis Laboratories Ltd (DIVISLAB)

₹3746.80.87%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q1 '23 Results
Technicals
News and Events

Overview of Divis Laboratories Ltd

Key events for Divis Laboratories Ltd

  • Divis Laboratories Among Top Gainers - 14 Sep, 2023

    Divis Laboratories Ltd saw a rise in stock prices, with the company emerging as one of the top gainers on the Nifty index.

  • Vaishali Recommends Buying Divi's Laboratories - 13 Sep, 2023

    An analyst recommends buying Divi's Laboratories stock at ₹3,787 with a stoploss of ₹3,700 and a target price of ₹3,900.

  • Divis Labs Shows Positive Trend; Major Gainer on Nifty50 - 12 Sep, 2023

    Divi's Laboratories Ltd showed a positive trend with support at ₹3700. It was among the major gainers on Nifty50.

  • Divi's Labs Shares Trade at 49% Discount to Historical PE - 07 Sep, 2023

    Shares of Divis Laboratories Ltd are trading at a significant discount to their historical price-to-earnings ratio, but the stock's average target price suggests a potential downside of 10%.

  • Divis Laboratories Among Top Gainers on Nifty 50 - 06 Sep, 2023

    Shares of Divi's Labs emerged as one of the top gainers on the Nifty 50, contributing to a rise in the Nifty Pharma index by around 1%.

  • Divi's Labs Among Top Laggards in Stock Market - 01 Sep, 2023

    Divis Laboratories Ltd was among the top laggards in the stock market as investors booked partial profits off pharma names. The Nifty Pharma also fell due to this trend.

  • Mixed Day for Divi's Laboratories Stock - 24 Aug, 2023

    Divi's Laboratories had a mixed day in the stock market as shares remained flat over the last month. Sukhani advised traders to buy the stock with a stop loss of Rs 3,600.

  • Divi's Labs Among Top Gainers in Nifty 50 - 23 Aug, 2023

    Divi's Laboratories Ltd gained up to 1.55% and was among the top gainers of Nifty 50 along with other companies like L&T, LTI Mindtree and Cipla.

  • Mixed Sentiments for Divis Laboratories Ltd. - 22 Aug, 2023

    Prabhudas Lilladher is bullish on Divi's Labs in the short term, but also introduced Sell Ideas. They recommend a stock-specific approach and avoiding sectors with weak fundamentals.

  • Divi's Laboratories Misses 1QFY24 Estimates, Earnings Reduced - 21 Aug, 2023

    Divi's Laboratories missed 1QFY24 estimates due to lower sales in generics and custom synthesis. EBITDA margin expanded sequentially owing to cost management activities. Earnings for FY24/FY25 reduced by 3%/5%. Neutral rating maintained as valuation factors in earnings upside over the next two years.

  • Divi's Labs Stock Falls Over Sales Miss and Expensive Valuations - 17 Aug, 2023

    Divi's Laboratories Ltd's Q1FY24 EBITDA was 12% below Prabhudas Lilladher's estimate led by lower revenues across segments. They have downgraded the stock to 'Reduce' from 'Hold' rating with a revised target price of Rs3,000/share. The stock has fallen over 5.3% in the last six trading sessions.

  • Mixed Day for Divis Laboratories Ltd - 16 Aug, 2023

    Divi's Laboratories' Q1 net profit declined 49.3% YoY to Rs 356 crore, missing estimates. However, the company has been identified as a global cost champion for several molecules.

  • Divi's Labs Reports Disappointing Q1 Results - 14 Aug, 2023

    Divi's Laboratories Ltd's Q1 profit fell by half, missing estimates due to pricing pressures. Despite this, the stock gained 1.87%. Technical analysis recommends a short Iron Condor strategy.

  • Divi's Labs Faces Weak Q1 Performance Expectations - 11 Aug, 2023

    Divis Laboratories Ltd faces expectations of a weak Q1 performance due to high base and margin pressure, resulting in estimated net profit fall of 42.6% YoY.

  • Divi's Laboratories Ltd Experiences Shift in Market Sentiment - 10 Aug, 2023

    The crossing of Divi's Laboratories Ltd's short-term and long-term moving averages signals a shift in market sentiment.

  • Divis Laboratories Stock Falls on Short Build-Up and Poor Performance - 09 Aug, 2023

    Divis Laboratories Ltd's stock experienced a short build-up, resulting in it being one of the worst-performing stocks on the Nifty 50.

  • Positive Outlook for Divi's Laboratories Stock - 07 Aug, 2023

    Experts recommend buying Divi's Laboratories with a stop loss of Rs 3,650 as the stock gains up to 2.87%. The company has shown positive growth potential.

  • Divi's Labs Among Top Gainers on Nifty 50 - 04 Aug, 2023

    Divi's Laboratories Ltd was among the top gainers on Nifty 50 along with other companies such as Adani Enterprise, Adani Ports & Special Economic Zone, Eicher Motors, and Hindalco Industries. Additionally, Divi's Labs' trading P/E ratio is 54.15.

  • Divis Laboratories Gains on Nifty 50 Index - 03 Aug, 2023

    Divis Laboratories Ltd showcases impressive market performance by surpassing its 20-day SMA and being recommended as a buy call by Sudarshan Sukhani.

  • Divis Laboratories Ends in Green Despite Market Fall - 02 Aug, 2023

    Despite a market fall, Divis Laboratories Ltd managed to end in the green and was among the top gainers on the Nifty 50. A sell call was made earlier in the day.

Analyst Rating

based on 23 analysts

HOLD
26.09%
Buy
30.43%
Hold
43.48%
Sell

Based on 23 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹3324.52

Source: S&P Global Market Intelligence

Divis Laboratories Ltd Performance

  • ₹3733.1
    ₹3798.2
    ₹3746.8
    downward going graph

    0.37%

    Downside

    Day's Volatility:1.74%

    Upside

    1.37%

    downward going graph
  • ₹2730
    ₹3934.7
    ₹3746.8
    downward going graph

    27.14%

    Downside

    52 Weeks Volatility:32.15%

    Upside

    5.01%

    downward going graph
1 Month Return3.12 %
3 Month Return7.69 %
1 Year Return5.76 %
Previous Close₹3,779.60
Open₹3,775.55
Volume2.62L
Market Cap₹1,00,336.50Cr

Divis Laboratories Ltd Company Information

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Share Price: ₹3746.80 per share as on 21 Sep, 2023 04:01 PM
Market Capitalisation: ₹1,00,336.50Cr as of today
Revenue: ₹2,016.92Cr as on March 2023 (Q1 23)
Net Profit: ₹320.97Cr as on March 2023 (Q1 23)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Divis Laboratories Ltd

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up
    img

    Mutual Funds have increased holdings from 13.15% to 13.20% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Profit Spike
    img

    Netprofit is up for the last 2 quarters, 306.8 Cr → 320.97 Cr (in ₹), with an average increase of 4.4% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up
    img

    Foreign Institutions have increased holdings from 14.68% to 14.70% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich
    img

    Revenue is up for the last 2 quarters, 1.82K Cr → 2.01K Cr (in ₹), with an average increase of 9.7% per quarter

  • imgNO EFFECT

    Against Peers
    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.0% return, outperforming this stock by 109.3%

  • imgNO EFFECT

    Against Peers
    img

    In the last 1 year, Dr Reddys Laboratories Ltd has given 35.2% return, outperforming this stock by 29.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down
    img

    Retail Investor have decreased holdings from 12.31% to 12.14% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Price Dip
    img

    In the last 7 days, DIVISLAB stock has moved down by -1.0%

  • imgNEGATIVE IMPACT

    Promoter Holding Down
    img

    Promoters have decreased holdings from 51.94% to 51.93% in Jun 2023 quarter

Divis Laboratories Ltd Valuation

Divis Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (48.78x)

September 20, 2023

Today (67.91x)

September 20, 2023

Highest (70.26x)

August 7, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
SBI Equity Hybrid Fund Direct GrowthSBI Equity Hybrid Fund Direct Growth3.82%
SBI Focused Equity Fund Direct Plan GrowthSBI Focused Equity Fund Direct Plan Growth4.99%
Axis Long Term Equity Fund Direct Plan Growth OptionAxis Long Term Equity Fund Direct Plan Growth Option4.37%
SBI Bluechip Fund Direct GrowthSBI Bluechip Fund Direct Growth2.57%
Axis Focused 25 Fund Direct Plan Growth OptionAxis Focused 25 Fund Direct Plan Growth Option5.54%

Divis Laboratories Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
51.93%
-0.02
Foreign Institutions
14.7%
0.16
Mutual Funds
13.2%
0.37
Retail Investors
12.14%
-1.42
Others
8.04%
1.43

Technicals of Divis Laboratories Ltd

News & Events of Divis Laboratories Ltd

News

Bajaj Auto New Products FY24 - Pulsar, Chetak & CNG Bike!

Bajaj Auto New Products FY24 - Pulsar, Chetak & CNG Bike! The Indian Automaker Is Expected To Launch All New Products Soon... Read more

20 Sep, 2023 03:00 PM

6 Bajaj Pulsars Coming In 6 Months; Bajaj CNG Bike May Also Be Incoming

Will there also be a CNG scooter? Here’s what Rajiv Bajaj had to say... Read more

20 Sep, 2023 05:31 PM

Bajaj Auto Share Price Live blog for 21 Sep 2023

Bajaj Auto stock price went up today, 21 Sep 2023, by 0.18 %. The stock closed at 5177.15 per share. The stock is currently trading at 5186.65 per share. Invest... Read more

21 Sep, 2023 08:07 AM
View More

Frequently Asked Questions

Divis Laboratories Ltd (DIVISLAB) share price today is ₹3746.8

  • Today’s highest price of Divis Laboratories Ltd is ₹3798.2.
  • Today’s lowest price of Divis Laboratories Ltd is ₹3733.1.

Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 2.62L.

Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹100336.5Cr.

Divis Laboratories Ltd(DIVISLABPrice
52 Week High
₹3934.7
52 Week Low
₹2730

Divis Laboratories Ltd(DIVISLAB) share price is ₹3746.8. It is down -4.78% from its 52 Week High price of ₹3934.7

Divis Laboratories Ltd(DIVISLAB) share price is ₹3746.8. It is up 37.25% from its 52 Week Low price of ₹2730

Divis Laboratories Ltd(DIVISLABReturns
1 Day Returns
-32.8%
1 Month Returns
3.12%
3 Month Returns
7.69%
1 Year Returns
5.76%